| Attention deficit hyperactivity disorder

Concerta vs QuilliChew ER

Side-by-side clinical, coverage, and cost comparison for attention deficit hyperactivity disorder.
Deep comparison between: Concerta vs Quillichew Er with Prescriber.AI
AI compares prescribing info and payer-specific access barriers across 1,200+ formularies. Here's a preview of what prescribers are already asking.
Safety signalsQuillichew Er has a higher rate of injection site reactions vs Concerta based on FDA-approved prescribing information
Coverage gaps3 major payers require step therapy for Quillichew Er but not Concerta, including UnitedHealthcare
Sign up to reveal the full AI analysis
Concerta
Quillichew Er
At A Glance
Oral
Once daily
CNS stimulant
Oral
Daily
CNS stimulant
Indications
  • Attention deficit hyperactivity disorder
  • Attention deficit hyperactivity disorder
Dosing
Attention deficit hyperactivity disorder 18 mg once daily in the morning (adults may start at 18 or 36 mg); swallow whole; titrate by 18 mg weekly; max 54 mg/day (ages 6-12), 72 mg/day (ages 13-65).
Attention deficit hyperactivity disorder Starting dose 20 mg once daily orally in the morning for patients 6 years and above; titrate weekly in increments of 10 mg, 15 mg, or 20 mg; doses above 60 mg/day have not been studied and are not recommended.
Contraindications
  • Known hypersensitivity to methylphenidate or other components of CONCERTA
  • Concomitant use of monoamine oxidase inhibitors (MAOIs), or within 14 days following MAOI discontinuation
  • Hypersensitivity to methylphenidate or other components of QuilliChew ER
  • Concomitant use with monoamine oxidase inhibitors (MAOIs) or within 14 days following MAOI discontinuation
Adverse Reactions
Most common (>=5%) Adults: decreased appetite, headache, dry mouth, nausea, insomnia, anxiety, dizziness, weight decreased, irritability, tachycardia, hyperhidrosis; pediatric patients 6 years and older: upper abdominal pain
Serious Hypersensitivity reactions (angioedema, anaphylaxis), hypertensive crisis with MAOIs, increased blood pressure and heart rate, psychiatric adverse reactions, priapism, peripheral vasculopathy including Raynaud's phenomenon, long-term growth suppression in pediatric patients
Postmarketing Pancytopenia, thrombocytopenia, angina pectoris, bradycardia, supraventricular tachycardia, hepatocellular injury, acute hepatic failure, convulsion, stroke, serotonin syndrome, hallucination, mania, priapism, alopecia, Raynaud's phenomenon, rhabdomyolysis
Most common (>=2%) Decreased appetite, aggression, emotional poverty, nausea, headache, weight decreased
Postmarketing Pancytopenia, thrombocytopenia, angina pectoris, severe hepatocellular injury, angioedema, anaphylactic reactions, convulsion, dyskinesia, serotonin syndrome, hallucination, mania, priapism, rhabdomyolysis, Raynaud's phenomenon
Pharmacology
Methylphenidate is a CNS stimulant that blocks reuptake of norepinephrine and dopamine into the presynaptic neuron and increases release of these monoamines into the extraneuronal space; its therapeutic mechanism in ADHD is not fully known.
Methylphenidate is a CNS stimulant that blocks the reuptake of norepinephrine and dopamine into the presynaptic neuron and increases the release of these monoamines into the extraneuronal space; the d-isomer is more pharmacologically active than the l-isomer.
Enter your patient's insuranceCheck specific coverage details for your patient.
Most Common Insurance
Anthem BCBS
Concerta
  • Covered on 5 commercial plans
  • PA (10/12) · Step Therapy (9/12) · Qty limit (10/12)
View full coverage details ›
Quillichew Er
  • Covered on 5 commercial plans
  • PA (10/12) · Step Therapy (10/12) · Qty limit (10/12)
View full coverage details ›
UnitedHealthcare
Concerta
  • Covered on 4 commercial plans
  • PA (0/8) · Step Therapy (0/8) · Qty limit (1/8)
View full coverage details ›
Quillichew Er
  • Covered on 4 commercial plans
  • PA (0/8) · Step Therapy (0/8) · Qty limit (0/8)
View full coverage details ›
Humana
Concerta
  • Covered on 0 commercial plans
  • PA (3/3) · Step Therapy (0/3) · Qty limit (3/3)
View full coverage details ›
Quillichew Er
  • Covered on 0 commercial plans
  • PA (1/3) · Step Therapy (1/3) · Qty limit (3/3)
View full coverage details ›
Coverage data sourced from MMIT. Updated monthly.
Savings
No savings programs available for Concerta.
No savings programs available for Quillichew Er.
Compare Other Drugs
Let us handle your prior authsJust enter your patient's info and we'll:
  • Verify eligibility with the payer.
  • Pull the right PA forms directly from the payer.
  • Submit, track & send live updates to your dashboard.
Utilize patient records to autofill forms with our AI in seconds.
Free to start · HIPAA compliant
Next Steps for Your Patient
ConcertaView full Concerta profile
Quillichew ErView full Quillichew Er profile
Clinical data sourced from FDA-approved labeling. Coverage data via MMIT. Updated monthly.